Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07822334) titled 'A Study of RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease' on Sept. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Hoffmann-La Roche
Condition:
Chronic Obstructive Pulmonary Disease (COPD)
Healthy Participants
Intervention:
Drug: RO7830698
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: October 20, 2026
Target Sample Size: 104
To know more, visit https://...